Thermo Fisher Scientific | TMO - Sales Revenues



Thermo Fisher Scientific reported $10.85B in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Abbott USD 11.42B 1.06B Jun/2025
Agilent USD 1.74B 68M Jul/2025
Becton, Dickinson and Co. USD 5.5B 230M Jun/2025
Bio Techne USD 317M 820K Jun/2025
Bio-Rad Laboratories USD 651.6M 66.2M Jun/2025
Boston Scientific USD 5.06B 400M Jun/2025
Bruker USD 797.4M 4M Jun/2025
Charles River Laboratories USD 1.03B 45.8M Jun/2025
Danaher USD 5.94B 200M Jun/2025
Dentsply International USD 936M 57M Jun/2025
Edwards Lifesciences USD 1.53B 120M Jun/2025
Exact Sciences USD 811.1M 104.1M Jun/2025
General Electric Aerospace USD 10.15B 210M Jun/2025
Henry Schein USD 3.2B 30M Jun/2025
Hologic USD 1.02B 10M Jun/2025
Illumina USD 1.06B 20M Jun/2025
Intuitive Surgical USD 2.44B 190M Jun/2025
IQVIA Holdings USD 4.02B 190M Jun/2025
Laboratory Of America USD 3.53B 180M Jun/2025
Medtronic USD 8.6B 330M Jun/2025
Mettler Toledo International USD 983.22M 99.48M Jun/2025
Myriad Genetics USD 213.1M 17.2M Jun/2025
Olympus JPY 206.51B 65.6B Jun/2025
Quest Diagnostics USD 2.76B 110M Jun/2025
Repligen USD 182M 13M Jun/2025
Revvity USD 720M 55M Jun/2025
Stryker USD 6.02B 120M Jun/2025
Thermo Fisher Scientific USD 10.85B 490M Jun/2025
Veracyte USD 130.16M 15.69M Jun/2025
Waters USD 771M 109M Jun/2025
Zimmer Biomet Holdings USD 2.08B 170M Jun/2025